[1]
Khan, Z. et al. 2017. COMPARISON OF ROSUVASTATIN WITH ATORVASTATIN IN LOWERING LOW DENSITY LIPOPROTEIN CHOLESTEROL AMONG DYSLIPIDEMIC PATIENTS. Journal of Medical Sciences. 25, 1 Suppleme (Mar. 2017), 137–140.